Histology - lmmunohistochemistry Module
组织学-免疫组织化学模块
基本信息
- 批准号:8539815
- 负责人:
- 金额:$ 20.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelAntibodiesAreaBiochemicalCancer BiologyCell modelCultured CellsEvaluationFreezingFundingHistologyLifeMalignant NeoplasmsMentorsMicroscopeMicroscopicMicroscopyModelingOklahomaParaffin EmbeddingPhaseResearch PersonnelSlideStaining methodStainsTissuesTraininganimal tissueanticancer researchcellular imaginginstrumenttissue culturetissue processing
项目摘要
The purpose of the Histology, Immunostaining, Microscopy Core is to provide to the Promising Junior Investigators (PJIs) and cancer funded investigators, tissue processing, embedding, sectioning, histochemical staining of mounted slides, developing immunohistochemical (IHC) (brighfield or fluorescent) staining for paraffin embedded and frozen tissues and immunocytochemical (ICC) (brighfield or fluorescent) staining for cultured cells, evaluation of new antibodies for IHC staining, biochemical and special staining. The core will provide technical support to all scientific investigators in the above said areas; with PJIs having first priority. The core will also provide training on and use of various microscopes including conventional bright field, phase and epifluorescence microscopy as well as new instruments for live cell imaging. This facility is critical for cancer investigators using animal models and tissue culture models to study basic mechanisms of cancer biology.
组织学、免疫染色、显微镜核心的目的是为有前途的初级研究者(PJIs)和癌症资助的研究者提供组织处理、包埋、切片、固定载玻片的组织化学染色、免疫组织化学(IHC)显影石蜡包埋和冷冻组织的(亮场或荧光)染色和免疫细胞化学(ICC)用于培养细胞的荧光染色(brighfield或荧光)、用于IHC染色的新抗体的评估、生物化学和特殊染色。该核心将为上述领域的所有科学调查人员提供技术支持; PJIs具有优先权。该中心还将提供各种显微镜的培训和使用,包括传统的明场、相位和落射荧光显微镜以及用于活细胞成像的新仪器。该设施对于癌症研究人员使用动物模型和组织培养模型研究癌症生物学的基本机制至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kar-Ming Fung其他文献
Kar-Ming Fung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kar-Ming Fung', 18)}}的其他基金
Tissue Pathology and Biospecimen Shared Resource
组织病理学和生物样本共享资源
- 批准号:
10627040 - 财政年份:2018
- 资助金额:
$ 20.77万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.77万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.77万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.77万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.77万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 20.77万 - 项目类别:














{{item.name}}会员




